The new vaccines against SARS-CoV-2 are novel in terms of specificity, their wide
dissemination across the global population and the inclusion of newly licensed mRNA …

Strategies of improving vaccine targeting ability toward lymph nodes have been attracting
considerable interest in recent years, though there are remaining delivery barriers based on …

Myocarditis and pericarditis have been linked recently to COVID-19 vaccines without
exploring the underlying mechanisms, or compared to cardiac adverse events post-non …

Influenza A virus is one of the most important zoonotic pathogens that can cause severe
symptoms and has the potential to cause high number of deaths and great economic loss …

Adenovirus was originally used as a vector for gene therapy. In recent years, with the
development of the next-generation vectors with increased safety and high immunogenicity …

Nano-based systems can be used to transport active medicinal products to specific parts of
the body. Most challenges with drug delivery, such as low water solubility and poor …

Although cancer immunotherapy is a compelling approach against cancer, its effectiveness
is hindered by the challenge of generating a robust and durable immune response against …

There are several emerging strategies for the vaccination of COVID-19 (SARS-CoV-2)
however, only a few have yet shown promising effects. Thus, choosing the right pathway and …

Vaccines to prevent acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection elicit
an immune neutralizing response. Some concerns have been raised regarding the safety of …

The avian influenza A virus (AIV) is naturally prevalent in aquatic birds, infecting different
avian species and transmitting from birds to humans. Both AIVs, the H5N1 and H7N9 …